Mindset Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
TORONTO, Oct. 6, 2021 /PRNewswire/ -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that James Lanthier, CEO of Mindset, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.
Mr. Lanthier will present live on Thursday, October 14th at 10:00 a.m. ET. Register to attend here.
For more information about the conference, or to schedule a one-on-one meeting with Mindset's management team, please contact KCSA Strategic Communications at MindSet@kcsa.com.
About Virtual Investor Conferences®
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
Learn more about VIC and its events at www.virtualinvestorconferences.com.
About Mindset Pharma
For further information on Mindset, please visit our website at www.mindsetpharma.com.
This news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward looking information is frequently characterized bywords such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Additional information regarding risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form for the financial year ended June 30, 2020 dated March 5, 2021. The forward-looking information included in this news release is made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise, except as required by applicable law.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mindset-pharma-to-present-at-the-kcsa-psychedelics-virtual-investor-conference-on-october-14th-301393848.html
Company Codes: CNSX:MSET, Frankfurt:9DF, OTC-PINK:MSSTF, OTC-QB:MSSTF
© 2021 PR Newswire. All Rights Reserved.